Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Chemical Research in Toxicology
|
August 24, 1999
2,2',3,3',6,6'-hexachlorobiphenyl hydroxylation by active site mutants of cytochrome P450 2B1 and 2B11
S C Waller, Y A He, G R Harlow, et al.
Chemical Research in Toxicology
|
May 23, 2001
Influence of P450 3A4 SRS-2 residues on cooperativity and/or regioselectivity of aflatoxin B(1) oxidation
L Xue, H F Wang, Q Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 4, 1999
Induction of cytochrome P-450 enzymes after repeated exposure to 4-vinylcyclohexene in B6C3F1 mice
J K Doerr-Stevens, J Liu, G J Stevens, et al.
Biochemistry
|
October 8, 1997
Significance of glycine 478 in the metabolism of N-benzyl-1-aminobenzotriazole to reactive intermediates by cytochrome P450 2B1
U M Kent, I H Hanna, G D Szklarz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 25, 1999
Identification of selective mechanism-based inactivators of cytochromes P-450 2B4 and 2B5, and determination of the molecular basis for differential susceptibility
S M Strobel, G D Szklarz, Y He, et al.
Biochemistry
|
September 9, 1998
Structure-function relationships of human liver cytochromes P450 3A: aflatoxin B1 metabolism as a probe
H Wang, R Dick, H Yin, et al.
The Journal of Biological Chemistry
|
November 25, 1991
Molecular basis for a functionally unique cytochrome P450IIB1 variant
K M Kedzie, C A Balfour, G Y Escobar, et al.
Molecular Pharmacology
|
August 1, 1994
Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity
J A Hasler, G R Harlow, G D Szklarz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 23, 1998
Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolism
J R Halpert, T L Domanski, O Adali, et al.
Pharmacogenetics
|
December 12, 2001
The genetic determinants of the CYP3A5 polymorphism
E Hustert, M Haberl, O Burk, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Chemical Research in Toxicology
|
August 24, 1999
2,2',3,3',6,6'-hexachlorobiphenyl hydroxylation by active site mutants of cytochrome P450 2B1 and 2B11
S C Waller, Y A He, G R Harlow, et al.
Chemical Research in Toxicology
|
May 23, 2001
Influence of P450 3A4 SRS-2 residues on cooperativity and/or regioselectivity of aflatoxin B(1) oxidation
L Xue, H F Wang, Q Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 4, 1999
Induction of cytochrome P-450 enzymes after repeated exposure to 4-vinylcyclohexene in B6C3F1 mice
J K Doerr-Stevens, J Liu, G J Stevens, et al.
Biochemistry
|
October 8, 1997
Significance of glycine 478 in the metabolism of N-benzyl-1-aminobenzotriazole to reactive intermediates by cytochrome P450 2B1
U M Kent, I H Hanna, G D Szklarz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 25, 1999
Identification of selective mechanism-based inactivators of cytochromes P-450 2B4 and 2B5, and determination of the molecular basis for differential susceptibility
S M Strobel, G D Szklarz, Y He, et al.
Biochemistry
|
September 9, 1998
Structure-function relationships of human liver cytochromes P450 3A: aflatoxin B1 metabolism as a probe
H Wang, R Dick, H Yin, et al.
The Journal of Biological Chemistry
|
November 25, 1991
Molecular basis for a functionally unique cytochrome P450IIB1 variant
K M Kedzie, C A Balfour, G Y Escobar, et al.
Molecular Pharmacology
|
August 1, 1994
Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity
J A Hasler, G R Harlow, G D Szklarz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 23, 1998
Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolism
J R Halpert, T L Domanski, O Adali, et al.
Pharmacogenetics
|
December 12, 2001
The genetic determinants of the CYP3A5 polymorphism
E Hustert, M Haberl, O Burk, et al.
Page
of 10